Geng Xu
Amsterdam, NH 1081HV, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The Neutrophil-NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities.
Journal: Biomolecules
Published: February 02, 2026
CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives.
Journal: Expert opinion on therapeutic targets
Published: October 08, 2025
Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancer.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: July 12, 2025
Novel Pyrazolo [1,5-a]-1,3,5-Triazine Derivatives as CDK7 Inhibitors: Synthesis and Biological Insights in Pancreatic Ductal Adenocarcinoma Models.
Journal: ChemMedChem
Published: June 02, 2025
Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer.
Journal: Biomolecules
Published: May 19, 2025
The Oral Microbiome and Cancer.
Journal: Advances in experimental medicine and biology
Published: March 20, 2025
Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 31, 2025
Navigating the paradox of senescence and chemoresistance in pancreatic cancer.
Journal: Seminars in cancer biology
Published: January 08, 2025
Corrigendum to "Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer models" [Bioorg. Chem. 153 (2024) 107959].
Journal: Bioorganic chemistry
Published: November 30, 2024
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer.
Journal: Expert opinion on investigational drugs
Published: October 22, 2024
Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer models.
Journal: Bioorganic chemistry
Published: September 27, 2024
Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis, mechanistic insights and promising antitumor and safety profile.
Journal: Journal of drug targeting
Published: July 27, 2024
Last Updated: 09/26/2026